• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

典型和非典型溶血尿毒综合征的病理生理学与治疗

Pathophysiology and treatment of typical and atypical hemolytic uremic syndrome.

作者信息

Picard C, Burtey S, Bornet C, Curti C, Montana M, Vanelle P

机构信息

Pharmacie usage intérieur, hôpital Timone, AP-HM, 13005 Marseille, France.

Centre de néphrologie et de transplantation rénale, hôpital de la Conception, AP-HM, 13005 Marseille, France.

出版信息

Pathol Biol (Paris). 2015 Jun;63(3):136-43. doi: 10.1016/j.patbio.2015.03.001. Epub 2015 Apr 3.

DOI:10.1016/j.patbio.2015.03.001
PMID:25845294
Abstract

Hemolytic uremic syndrome is a rare disease, frequently responsible for renal insufficiency in children. Recent findings have led to renewed interest in this pathology. The discovery of new gene mutations in the atypical form of HUS and the experimental data suggesting the involvement of the complement pathway in the typical form, open new perspectives for treatment. This review summarizes the current state of knowledge on both typical and atypical hemolytic uremic syndrome pathophysiology and examines new perspectives for treatment.

摘要

溶血尿毒综合征是一种罕见疾病,常导致儿童肾功能不全。近期的研究结果引发了对这种病症的新关注。非典型溶血尿毒综合征中新基因突变的发现以及提示补体途径参与典型溶血尿毒综合征的实验数据,为治疗开辟了新前景。本文综述了典型和非典型溶血尿毒综合征病理生理学的当前知识状态,并探讨了新的治疗前景。

相似文献

1
Pathophysiology and treatment of typical and atypical hemolytic uremic syndrome.典型和非典型溶血尿毒综合征的病理生理学与治疗
Pathol Biol (Paris). 2015 Jun;63(3):136-43. doi: 10.1016/j.patbio.2015.03.001. Epub 2015 Apr 3.
2
Hemolytic uremic syndrome: differential diagnosis with the onset of inflammatory bowel diseases.溶血性尿毒症综合征:与炎症性肠病发作的鉴别诊断。
Acta Biomed. 2018 Dec 17;89(9-S):153-157. doi: 10.23750/abm.v89i9-S.7911.
3
CFH gene mutation in a case of Shiga toxin-associated hemolytic uremic syndrome (STEC-HUS).一例志贺毒素相关性溶血尿毒综合征(STEC-HUS)中的CFH基因突变
Pediatr Nephrol. 2016 Jan;31(1):157-61. doi: 10.1007/s00467-015-3207-2. Epub 2015 Sep 23.
4
Use of complement monoclonal antibody eculizumab in Shiga toxin producing Escherichia coli associated hemolytic uremic syndrome: A review of current evidence.应用补体单克隆抗体依库珠单抗治疗产志贺毒素大肠埃希菌相关性溶血尿毒综合征:对现有证据的综述。
Pediatr Blood Cancer. 2019 Nov;66(11):e27913. doi: 10.1002/pbc.27913. Epub 2019 Jul 9.
5
Eculizumab in severe Shiga-toxin-associated HUS.依库珠单抗治疗重症志贺毒素相关性溶血尿毒综合征
N Engl J Med. 2011 Jun 30;364(26):2561-3. doi: 10.1056/NEJMc1100859. Epub 2011 May 25.
6
Posttransplant recurrence of atypical hemolytic uremic syndrome.移植后非典型溶血尿毒综合征复发。
J Nephrol. 2012 Nov-Dec;25(6):911-7. doi: 10.5301/jn.5000146.
7
Management of hemolytic uremic syndrome.溶血尿毒综合征的管理
Presse Med. 2012 Mar;41(3 Pt 2):e115-35. doi: 10.1016/j.lpm.2011.11.013. Epub 2012 Jan 27.
8
Complement Gene Variants and Shiga Toxin-Producing -Associated Hemolytic Uremic Syndrome: Retrospective Genetic and Clinical Study.补体基因变异与产志贺毒素相关的溶血尿毒综合征:回顾性遗传与临床研究。
Clin J Am Soc Nephrol. 2019 Mar 7;14(3):364-377. doi: 10.2215/CJN.05830518. Epub 2019 Jan 23.
9
Hemolytic uremic syndrome in children.儿童溶血性尿毒症综合征
Minerva Pediatr. 2016 Dec;68(6):441-455.
10
Pathogenesis and treatment of Shiga toxin-producing Escherichia coli infections.产志贺毒素大肠杆菌感染的发病机制与治疗
Curr Opin Gastroenterol. 2008 Jan;24(1):38-47. doi: 10.1097/MOG.0b013e3282f2dfb8.

引用本文的文献

1
Haemolytic uraemic syndrome in children England, Wales, Northern Ireland, and Ireland: A prospective cohort study.儿童溶血尿毒综合征:英格兰、威尔士、北爱尔兰和爱尔兰的前瞻性队列研究。
Epidemiol Infect. 2023 Sep 1;151:e160. doi: 10.1017/S0950268823001413.
2
Thrombotic thrombocytopenic purpura with neurological impairment: A Review.血栓性血小板减少性紫癜伴神经功能障碍:综述。
Medicine (Baltimore). 2022 Dec 9;101(49):e31851. doi: 10.1097/MD.0000000000031851.
3
Development and pilot implementation of Iranian Hemolytic Uremic Syndrome Registry.
伊朗溶血尿毒综合征注册中心的建立与初步实施。
Orphanet J Rare Dis. 2022 Jun 16;17(1):228. doi: 10.1186/s13023-022-02376-9.
4
Hemolytic-uremic syndrome: 24 years' experience of a pediatric nephrology unit.溶血尿毒综合征:儿科肾病科 24 年的经验。
J Bras Nefrol. 2023 Jan-Mar;45(1):51-59. doi: 10.1590/2175-8239-JBN-2021-0206.
5
Eculizumab Use in a Temporarily Dialysis-Dependent Patient With Shiga Toxin-Producing Hemolytic Uremic Syndrome With Neurological Complications.依库珠单抗在一名依赖临时透析的产志贺毒素溶血尿毒综合征伴神经系统并发症患者中的应用。
J Pediatr Pharmacol Ther. 2022;27(1):90-95. doi: 10.5863/1551-6776-27.1.90. Epub 2021 Dec 22.
6
Atypical hemolytic uremic syndrome in the Colombian Caribbean: its particular characteristics.哥伦比亚加勒比地区非典型溶血尿毒综合征:其特殊特征。
Int Urol Nephrol. 2022 Jun;54(6):1323-1330. doi: 10.1007/s11255-021-03011-5. Epub 2021 Oct 13.
7
Whole-genome characterization of hemolytic uremic syndrome-causing Shiga toxin-producing in Sweden.瑞典产志贺毒素溶血性尿毒症综合征相关菌株的全基因组特征分析。
Virulence. 2021 Dec;12(1):1296-1305. doi: 10.1080/21505594.2021.1922010.
8
Interventions for atypical haemolytic uraemic syndrome.非典型溶血性尿毒综合征的治疗。
Cochrane Database Syst Rev. 2021 Mar 23;3(3):CD012862. doi: 10.1002/14651858.CD012862.pub2.
9
Therapeutic Strategies to Protect the Central Nervous System against Shiga Toxin from Enterohemorrhagic .针对肠出血性大肠杆菌产生的志贺毒素保护中枢神经系统的治疗策略
Curr Neuropharmacol. 2021;19(1):24-44. doi: 10.2174/1570159X18666200220143001.
10
Cathelicidin- derived PR39 protects enterohemorrhagic Escherichia coli O157:H7 challenged mice by improving epithelial function and balancing the microbiota in the intestine.抗菌肽 PR39 可改善肠上皮功能和平衡肠道微生物群,从而保护感染肠出血性大肠杆菌 O157:H7 的小鼠。
Sci Rep. 2019 Jul 1;9(1):9456. doi: 10.1038/s41598-019-45913-6.